Sign In to Follow Application
View All Documents & Correspondence

“Method For Increasing Methionine Productivity Using A Mixture Of Methyl Mercaptan And Dimethyl Sulfide”

Abstract: The present invention relates to a method for increasing L-methionine productivity and organic acid productivity. More particularly  the present invention relates to a method which involves adding a mixture containing methyl mercaptan and dimethyl sulfide at a appropriate appropriateratioto O-acetyl homoserine or O-succinyl homoserine and to an enzyme having an activity of converting methionine precursor into L-methionine  so as to perform an enzyme reaction  to thereby improve the conversion rate of L-methionine and organic acid from the L-methionine precursor  and thus increasing L-methionine yield as compared to conventional method.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
26 August 2011
Publication Number
51/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2017-07-11
Renewal Date

Applicants

CJ CHEILJEDANG CORPORATION
292  Ssangnim-dong  Jung-gu  Seoul 100-400  Republic of Korea

Inventors

1. KIM  So Young
908-305  Jugong Apt.  Burim-dong  Gwacheon-si  Gyeonggi-do 427-736  Republic of Korea
2. SHIN  Yong Uk
433-902  Hyundai Hometown 4-cha 3-danji Apt.  Jukjeon 1-dong  Suji-gu  Yongin-si  Gyeonggi-do 448-972  Republic of Korea
3. HEO  In Kyung
101-1311  Travi House  Deungchon 1-dong  Gangseo-gu  Seoul 157-031  Republic of Korea
4. KIM  Hyun Ah
138  Singye-ri  Daesan-myeon  Namwon-si  Jeollabuk-do 590-972  Republic of Korea
5. KIM  Ju Eun
814  Humanvill Officetel  1479-9 Gayang-dong  Gangseo-gu  Seoul 157-200  Republic of Korea
6. SEO  Chang Il
Unit 303  3-73 Hwapyeong-dong  Dong-gu  Incheon 401-030  Republic of Korea
7. SON  Sung Kwang
106-1402  Kunyoung 2-cha Apt.  Junggye 3-dong  Nowon-gu  Seoul 139-925  Republic of Korea
8. LEE  Sang Mok
107-304  Magoksumyeongsan Park  Naebalsan-dong  Gangseo-gu  Seoul 157-931  Republic of Korea
9. JHON  Sung Hoo
203-404  Dosigaebal Apt.  1461 Gayang-dong  Gangseo-gu  Seoul 157-200  Republic of Korea
10. LEE  Han Jin
102-304  Daewoo Apt.  Jeongneung 4-dong  Seongbuk-gu  Seoul 136-767  Republic of Korea
11. NA  Kwang Ho
308  2-danji  Dosigyebal Apt.  Gayang 1-dong  Gangseo-gu  Seoul 157-201  Republic of Korea
12. KIM  Il Chul
301-904  Cheongsolmaeul Halla Apt.  Geumgok-dong  Bundang-gu  Seongnam-si  Gyeonggi-do 463-725  Republic of Korea

Specification

BACKGROUND OF THE INVENTION Field of the Invention
The present invention relates to a method for improving productivity of L-methionine and organic acid.
Description of the Related Art
Methionine is one of the essential amino acids in the body, and has been widely used as an animal feed and food additive, as well as a component of medical aqueous solutions and other raw material for medicinal products. Methionine acts as a precursor of choline (lecithin) and creatine, and is also used as a raw material for the synthesis of cysteine and taurine. In addition, it functions as a sulfur donor. S-adenosyl-methionine is derived from L-methionine and serves as a methyl donor in the body, and it is involved in the synthesis of various neurotransmitters in the brain. Methionine and/or S-adenosyl-L-methionine (SAM) is/are also found to prevent lipid accumulation in the liver and arteries and to be effective for the treatment of depression, inflammation, liver diseases and muscle pain (Jeon BR et al., J Hepatol., 2001 Mar; 34(3): 395-401).
For the chemical synthesis of methionine, L-methionine is produced through the hydrolysis of 5-(β-methylmercaptoethyl)-hydantoin. However, the chemically synthesized methionine is disadvantageously present in a mixture of L- and D-forms. Therefore, the present inventors developed a biological method for selectively synthesizing L-methionine, and have already applied for a patent (WO 2008/103432). The method, is termed briefly as “a two-step process”, comprises the fermentative production of an L-methionine precursor and the enzymatic conversion of the L-methionine precursor to L-methionine. The L-methionine precursor preferably includes O-acetyl homoserine and O-succinyl homoserine. The two-step process is evaluated in terms of having overcome the problems

from which the conventional methods suffer, such as sulfide toxicity, feedback regulation of strain by methionine and SAMe, and degradation of intermediates by cystathionine gamma synthase, O-succinyl homoserine sulfhydrylase and O-acetyl homoserine sulfhydrylase. Also, compared to the conventional chemical synthesis method of producing D- and L-methionine, the two-step process has the advantage of being selective for L-methionine only, with the concomitant production of organic acids, more particularly, succinic acid and acetic acid as useful by-products. The succinic acid is used as a raw material of paints, cosmetics, or medicinal products, and acetic acid is very useful in industrial fields, including preparation of vinyl acetic acid, staining, medicinal products such as aspirin, and photographic fixing solutions.
In the enzymatic conversion reaction of the two-step process, enzymes which have the activities of cystathionine gamma synthase, O-succinyl homoserine sulfhydrylase and O-acetyl homoserine sulfhydrylase are used, and O-acetyl homoserine or O-succinyl homoserine as the L-methionine precursor is mixed with methyl mercaptan to produce L-methionine and an organic acid by enzymatic reaction.
Methyl mercaptan exists as a gas at room temperature, and is slightly soluble in water, and has a high solubility in alkaline solutions. The enzymatic conversion reaction for L-methionine production occurs in an aqueous solution. Thus, if methyl mercaptan has a more improved solubility in the aqueous solution, it is expected to greatly increase methionine productivity.
Considering the above problem, the present inventors have made an effort to increase the solubility of methyl mercaptan in the enzymatic conversion reaction for maximization of L-methionine production. As a result, they found that a mixture of methyl mercaptan and dimethyl sulfide mixed at a appropriate ratio can improve the conversion rate of L-methionine and organic acid from L-methionine precursor, and thus L-methionine can be produced in a high yield, compared to the conventional methods, thereby completing the present invention.

SUMMARY OF THE INVENTION
It is an object of the present invention to provide a method for improving the conversion rate from the L-methionine precursor, O-acetyl homoserine or O-succinyl homoserine to the L-methionine, by using the mixture of a sulfur compound, dimethyl sulfide and the methyl mercaptan, which is another sulfur compound used as a substrate in an enzymatic conversion reaction.
Effect of the invention
By using the method of the present invention, the production rate and purity of L-methionine and organic acid can be increased compared to the single use of methyl mercaptan during the conversion reaction. Moreover, economic benefits of saving cost for reaction facility can be obtained by the improved methionine productivity.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a graph of pH change showing the rate of enzymatic conversion reaction according to the supply of a methyl mercaptan solution or a mixture of methyl mercaptan and dimethyl sulfide solution in a 1L batch reactor; and
FIG. 2 is a graph showing relative activity according to the mixing ratio of methyl mercaptan solution (SMM) and dimethyl sulfide (DMS).
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
In order to achieve the above object, an aspect of the present invention is to provide a method for producing methionine, comprising:
1) preparing a reaction solution that includes a methionine precursor which is an O-acetyl homoserine or an O-succinyl homoserine, an enzyme which has the activity of converting the methionine precursor into methionine, and a mixture of methyl mercaptan and dimethyl sulfide; and
2) performing an enzymatic conversion reaction while stirring the reaction solution.

The term “two-step process”, as used herein, refers to a method for producing L-methionine disclosed in WO2008/013432, comprising the steps of producing O-acetyl homoserine or O-succinyl homoserine by glucose fermentation using a fermentation strain prepared according to the method; and converting O-acetyl homoserine or O-succinyl homoserine, together with methyl mercaptan, into methionine by enzymatic conversion, thereby producing L-methionine.
Hereinafter, the present invention will be described in detail.
An aspect of the present invention is to provide a method for producing methionine, comprising:
1) preparing a reaction solution that includes a methionine precursor which is an O-acetyl homoserine or an O-succinyl homoserine, an enzyme which has the activity of converting the methionine precursor into methionine, and a mixture of methyl mercaptan and dimethyl sulfide; and
2) performing an enzymatic conversion reaction while stirring the reaction solution.
The stirring of step 2) may be performed at 500 to 1000 rpm, preferably 600 to 900 rpm, and more preferably 700 to 800 rpm.
The method of the present invention may further comprise terminating the enzymatic conversion reaction, and in the specific embodiment of the present invention, 2N HCl is used to terminate the reaction.
In addition, the method of the present invention may further comprise purification of methionine presented in the reaction solution. In particular, methionine purification step may comprise:
1) separating the microorganism from the enzymatic conversion reaction solution;

2) decoloring and filtering the reaction solution, of which the microorganism is removed; and
3) crystallizing from the filtrate.
The step of separating the microorganim may be performed using a high speed centrifuge or a membrane filter. The step of decoloring and filtering the microorganim-removed solution may be performed using an activated carbon, but is not limited thereto.
In the two-step process for producing methionine, methionine is produced by enzymatic conversion reaction using O-acetyl homoserine or O-succinyl homoserine as an L-methionine precursor and methyl mercaptan (CH3SH) as substrates (WO2008/013432). In this regard, methyl mercaptan is used as a sulfur source which can react with the substrate, O-acetyl homoserine or O-succinyl homoserine to produce methionine, and thus the production efficiency of methionine may be greatly affected by the reactivity of methyl mercaptan. However, methyl mercaptan has a very low solubility in a neutral aqueous solution, and is volatile and thus quickly evaporated from the solution. Therefore, if a method capable of improving the reactivity of methyl mercaptan is developed, the maximum amount of methyl mercaptan as possible can react before the evaporation of methyl mercaptan, so as to improve the production yield of methionine. Accordingly, the present inventors intended to improve the reactivity of methyl mercaptan by the addition of another material to the reaction solution containing methyl mercaptan. As a result, they found that when dimethyl sulfide (DMS) as another material is mixed with methyl mercaptan to induce the reaction, the conversion rate can be increased.
In the specific Example of the present invention, the conversion reaction does not occur when dimethyl sulfide is used alone. However, when the mixture of methyl mercaptan with dimethyl sulfide is used, the conversion rate is increased, compared to the single use of methyl mercaptan (see Tables 1 and 4, and FIG. 2). In addition, the reaction rate of enzyme was higher than that of the single use of methyl mercaptan, according to the rate of pH decline by acetic acid, which is a by-product produced by mixing with

dimethyl sulfide (see FIG. 1). Moreover, when a continuous supply of the mixture is performed (see Table 2) or a large-scale culture is performed (see Table 3), the conversion rates were also improved, compared to the single use of methyl mercaptan. Accordingly, the method of the present invention can be effectively used to improve the conversion rate of L-methionine from O-acetyl homoserine or O-succinyl homoserine.
The conversion reaction of methionine from methionine precursor using enzymes having an activity converting into methionine is as shown in the following Reaction Schemes.
Methyl mercaptan (CH3SH) + O-Succinyl-L-homoserine ↔ Succinate + L-Methionine
Methyl mercaptan (CH3SH) + O-Acetyl-L-homoserine ↔ Acetate + L-Methionine
In the above Reaction Schemes, the CH3S- residue of methyl mercaptan is substituted with the succinate or acetate residue of O-succinyl homoserine or O-acetyl homoserine to produce methionine.
Upon the reaction, methyl mercaptan (CH3SH) may be added in a variety of forms. Preferably, methyl mercaptan may be added in a form of methyl mercaptan gas or sodium methyl mercaptan solution may be also used as a liquid type, because the sodium methyl mercaptan solution and methyl mercaptan gas show the same reaction properties in an aqueous reaction solution. Therefore, the methyl mercaptan may be used directly, or in a form of sodium methyl mercaptan solution by solubilizing it in a sodium hydroxide solution. However, since methyl mercaptan exists as a gas at room temperature, it is more preferable to use the sodium methyl mercaptan solution prepared by solubilizing methyl mercaptan in a sodium hydroxide solution.
In the present invention, the enzyme which has an activity of converting into methionine may include one or more selected from the group consisting of cystathionine gamma synthase, O-succinyl homoserine sulfhydrylase, and O-acetyl homoserine sulfhydrylase.

In the above reaction, the enzymes having an activity of converting into methionine used in the production of methionine may be those derived from a microorganism strain belonging to Escherichia sp., Pseudomonas sp., Leptospira sp., Corynebacterium sp., Saccharomyces sp., Chromobacterium sp., Nocardia sp., Bradyrhizobium sp., Hyphomonas sp., Methylococcus sp., Methylobacillus sp., Nitrosomonas sp., Klesiella sp., Bacillus sp., Shigella sp., Colwellia sp., Salmonella sp., yeast, or fungi.
In the above conversion reaction, when O-succinyl homoserine is used as a substrate, the enzyme may include one or more selected from the group consisting of cystathionine gamma synthase, O-succinyl homoserine sulfhydrylase and O-acetyl homoserine sulfhydrylase, which are preferably derived from microorganism strains belonging to Pseudomonas sp., Nocardia sp., and Chromobacterium sp., and more preferably derived from microorganism strains belonging to Pseudomonas aurogenosa, Nocardia Farcinica, Pseudomonas putida, and Chromobacterium Violaceum.
In the above conversion reaction, when O-acetyl homoserine is used as a substrate, the enzyme may include one or more selected from the group consisting of cystathionine gamma synthase, O-succinyl homoserine sulfhydrylase and O-acetyl homoserine sulfhydrylase, which are preferably derived from microorganism strains belonging to Leptospira sp., Corynebacterium sp., and Hyphomonas sp., and more preferably derived from microorganism strains belonging to Leptospira meyeri, Pseudomonas aurogenosa, Hyphomonas Neptunium, and Corynebacterium Violaceum.
In the specific embodiment of the present invention, O-acetyl homoserine or O-succinyl homoserine that is used as a substrate in the conversion reaction for the production of L-methionine was produced by fermentation of the microorganism strain prepared according to the method described in WO2008/013432, and the substrate, O-acetyl homoserine or O-succinyl homoserine was purified from the fermented solution by methanol precipitation.

Further, the enzymes used in the conversion reaction for the production of L-methionine were obtained from the genes of O-succinyl homoserine sulfhydrylase derived from Chromobacterium violaceum and O-acetyl homoserine sulfhydrylase derived from Hyphomonas Neptunium, in which the strains containing the genes were fermented, recovered and then disrupted according to the method described in WO2008/013432.
The conversion reaction solution was prepared by mixing O-acetyl homoserine or O-succinyl homoserine, which was the substrate recovered by the above method, together with the enzyme which has an activity of converting into methionine.
The other substrate, methyl mercaptan was mixed with dimethyl sulfide at a appropriate ratio, and added to the conversion reaction solution, and the conversion rates of methionine from O-acetyl homoserine or O-succinyl homoserine was compared in each case. The results showed that a mixing ratio of methyl mercaptan and dimethyl sulfide was optimal when the methyl mercaptan:dimethyl sulfide ratio was 1:0.0.5 (mol:mol) to 1:1 (mol:mol), preferably 1:0.20 (mol:mol) to 1:1 (mol:mol), and more preferably 1:0.25 (mol:mol) to 1:0.5 (mol:mol). Meanwhile, dimethyl sulfide is preferably used at a ratio of 5% to 25%, and more preferably 20% to 25%, based on the molar concentration of methyl mercaptan.
Another aspect of the present invention is to provide methionine prepared by the above method.
The methionine may be in a dried powdery form or in a liquid form dissolved in an aqueous solution, which is purified by a purification process.
The method of converting L-methionine precursor into L-methionine using the mixture of methyl mercaptan and dimethyl sulfide according to the present invention is able to produce L-methionine at a higher yield than the conventional methods, and thus the produced methionine can be applied to various fields including animal feeds, food additives, medicines, and other raw materials for medicinal products.

Hereinafter, constitutions and effects of the present invention will be described in more detail with reference to Examples. However, these Examples are for illustrative purposes only, and the invention is not intended to be limited by these Examples.
Example 1: Comparison of Conversion Rate of Methionine from O-Acetyl homoserine according to Mixing Ratio of Methyl mercaptan and Dimethyl sulfide
Upon conversion reaction, dimethyl sulfide was mixed with a methyl mercaptan solution at a appropriate ratio, and the mixture was added to a conversion reaction solution so as to examine the conversion rate of methionine from O-acetyl homoserine.
Methyl mercaptan exists as a gas at room temperature, and may exist in a form of sodium methyl mercaptan solution (sodium methyl mercaptan, CH3S - Na, 2.14 M, 15%, Tokyo chemical industry, Japan) by adding it to a sodium hydroxide solution. In the present Example, a 2.14 M sodium methyl mercaptan solution was used to perform the experiment. Hereinbelow, the 2.14 M sodium methyl mercaptan solution will be designated as a methyl mercaptan solution. The methyl mercaptan solution and dimethyl sulfide solution (13.38 M, 99%, arkema, France) were mixed at a appropriate molar ratio (mol:mol), and stirred to prepare a mixed solution.
The conversion reaction solution was prepared by adding 50 µl of converting enzyme solution and 0.1 mM pyridoxal 5’-phosphate (Sigma, USA) as a cofactor to 1 ml of O-acetyl homoserine solution (500 mM). The O-acetyl homoserine solution was prepared by dissolving O-acetyl homoserine purified from a fermented liquid in a phosphate buffer solution (pH 7.5).
A CJM-BTJA/pCJ-metXlme-CL strain prepared by the method disclosed in WO2008/013432 was used as a fermentation strain. The CJM-BTJA/pCJ-metXlme-CL strain was inoculated in a 5L fermenter, and cultivation was performed by fed batch fermentation for 50~100 hrs. O-acetyl homoserine was purified from the fermented liquid by methanol precipitation. The converting enzyme was obtained from E. coli W3110 strain transformed with pCJ-MetZ-CL derived from Hyphomonas Neptunium, in which the

strain was fermented, and then recovered and disrupted according to the method disclosed in WO2008/013432. The mixture of methyl mercaptan and dimethyl sulfide was added to the prepared conversion reaction solution to initiate the enzyme reaction. In this regard, the added amount of the mixture of methyl mercaptan and dimethyl sulfide was adjusted until the final amount of methyl mercaptan became 0.04 mM. The reaction was performed at a temperature of 33°C and 800 rpm for 10 min under stirring. For the termination of the reaction, a 0.2 N HCl solution was added to terminate the reaction. A concentration of the final product methionine was analyzed by HPLC. The analysis was performed under the conditions disclosed in WO2008/013432.
The conversion rate (%) of methionine from O-acetyl homoserine was calculated from a percentage (%) of the number of moles of the produced methionine to the number of moles of the substrate (mol/L) used in the reaction. When 1 mol of methionine was produced from 1 mol of O-acetyl homoserine and methyl mercaptan, the conversion rate (%) was regarded as 100%. The analysis results are shown in the following Table 1.
As shown in Table 1, when a mixture of methyl mercaptan solution and dimethyl sulfide was added at a ratio of 1:0.25 (mol:mol), the production of methionine was increased to 34%, compared to the single use of methyl mercaptan. When the mixing ratio

of methyl mercaptan solution and dimethyl sulfide was increased to more than 1:0.25, the relative activity was not increased further, but was maintained at a high level.
As a control group, when dimethyl sulfide was only added to the conversion reaction solution in an amount identical to that contained in the 1:1 mixture of methyl mercaptan and dimethyl sulfide, the production of methionine was not observed, indicating that the single use of dimethyl sulfide cannot produce methionine. Therefore, it is suggested that dimethyl sulfide is mixed with methyl mercaptan to increase the reactivity of methyl mercaptan, thereby improving the production of methionine.
Example 2: Conversion Reaction of Methionine using Mixture of Methyl mercaptan and Dimethyl sulfide
To examine whether the improved production of methionine continuously occurs under the same conditions as in Example 1, the production of methionine was examined while the mixture of methyl mercaptan and dimethyl sulfide was continuously added according to time. The reaction was maintained using the same conversion reaction solution for 30 min while the methyl mercaptan solution and the mixture with dimethyl sulfide were added every 10 min. After 30 min, the reaction was terminated, and the amount of produced methionine was measured by HPLC. The reaction was performed under the condition of the mixing ratio of methyl mercaptan solution and dimethyl sulfide of 1:0.25 (mol:mol), at which the highest production of methionine was observed in Example 1. The results are shown in the following Table 2.

As shown in Table 2, the conversion rate was increased to approximately 15% after 30 min, compared to the single use of methyl mercaptan.
Example 3: Enzymatic Conversion Reaction of O-Acetyl homoserine in 1 L Batch reactor
To examine the efficiency of conversion reaction in a large-scale reactor, the reaction was performed using 500 mL of 700 mM O-acetyl homoserine in a 1L batch reactor. The enzymatic conversion reaction was performed while continuously supplying the methyl mercaptan solution or the mixture of methyl mercaptan and dimethyl sulfide of 1:0.25 (mol:mol) at a flow rate of 3.0 mL/min for 60 min. The amount of methyl mercaptan contained in each solution was adjusted to be identical. The reaction temperature was 33°C and the agitation was performed at 700 rpm. The converting enzyme liquid was prepared in the same manner as in the above Example, and 10 mL thereof was added. 0.1 mM pyridoxal 5’-phosphate (Sigma, USA) as a cofactor was added. After about 3 hrs, the amount of produced methionine was measured by HPLC. The results are shown in the following Table 3.
As shown in Table 3, when the mixture of methyl mercaptan solution and dimethyl sulfide was added at a ratio of 1:0.25 (mol:mol), the conversion rate was increased to approximately 18%, compared to the single use of methyl mercaptan.

Upon the conversion reaction of O-acetyl homoserine, acetate was also produced as a product in addition to methionine, and thus pH drop occurred. After initiation of the reaction, while the methyl mercaptan solution and the mixture of methyl mercaptan and dimethyl sulfide were supplied, pH increased because methyl mercaptan was supplied in the liquid form by dissolving it in NaOH. However, after completion of the supply, pH decreased. When acetic acid (in the case of using O-acetyl homoserine as a substrate) or succinic acid (in the case of using O-succinyl homoserine as a substrate) was produced as the by-products of the conversion reaction, the reaction rate of enzyme can be reflected by the rate of pH decline. As shown in FIG. 1, when the mixture of methyl mercaptan and dimethyl sulfide of 1:0.25 (mol:mol) was used, the reaction rate of enzyme according to the rate of pH decline was found to be relatively high, compared to the single use of methyl mercaptan.
Example 4: Enzymatic Conversion Reaction of O-Succinyl homoserine according to addition amount of dimethyl sulfide to methyl mercaptan
O-succinyl homoserine was also used as a substrate for the enzymatic conversion reaction of methionine so as to perform the reaction of producing methionine and succinic acid.
The different amounts of dimethyl sulfide were added to the methyl mercaptan solution in 1.5 mL tube scale as in Example 1, and then the conversion rates of methionine from O-succinyl homoserine were compared. Dimethyl sulfide was added at a ratio of methyl mercaptan to dimethyl sulfide of 1:0, 1:0.25, 1:0.35, and 1:1 (mol:mol). The conversion reaction liquid was prepared by adding 50 µl of the converting enzyme liquid and 0.1 mM pyridoxal 5’-phosphate as a cofactor to 1 ml of O-succinyl homoserine solution (500 mM). The O-succinyl homoserine solution was prepared by dissolving O-succinyl homoserine purified from a fermented liquid in a phosphate buffer solution (pH 7.5). A CJM-BTJ/pCJ-metA-CL strain prepared by the method disclosed in WO2008/013432 was inoculated in a 5L fermenter, and cultivation was performed by fed batch fermentation for 50~100 hrs. O-succinyl homoserine was purified from the

fermented liquid by methanol precipitation. The converting enzyme was obtained from E.coli W3110 strain transformed with pCJ-MetZ-CL derived from Chromobacterium violaceum, in which the strain was fermented, and then recovered and disrupted according to the method disclosed in WO2008/013432. 0.05 mL of the enzyme was added. 0.02 mL of each mixture of methyl mercaptan and dimethyl sulfide at the different ratios was added to the prepared conversion reaction solution so as to initiate the enzyme reaction. Each solution was adjusted to contain the identical amount of methyl mercaptan. The reaction was performed at a temperature of 33°C and 800 rpm for 10 min under stirring. For the termination of the reaction, a 0.2 N HCl solution was added to terminate the reaction. The concentration of the final product methionine was analyzed by HPLC. The results are shown in Table 4.
[Table 4]
Comparison of conversion rates of O-succinyl homoserine according to addition
amount
Mixing ratio of methyl mercaptan :
1:0 1:0.25 1:0.35 1:1
dimethyl sulfide (mol : mol)
Methionine [g/L] 4.3 4.6 4.7 4.5
Conversion rate [%] 86 94 95 92
Relative activity [%] 100 109 110 107
As shown in Table 4, when the mixture of methyl mercaptan solution and dimethyl sulfide was added at a ratio of 1:0.35 (mol:mol), the activity was increased to approximately 10%, compared to the single use of methyl mercaptan. When the mixture of methyl mercaptan and dimethyl sulfide was added at a ratio of 1:0.25 and 1:1 (mol:mol), the enzymatic activity was not greatly increased, compared to the mixture ratio of 1:0.35 (mol:mol), but each of the enzymatic activity was increased to approximately 9% and 7%, compared to the single use of methyl mercaptan.

As described in the above Examples, the present invention provides a method of increasing conversion rate of methionine, thereby being applied to various fields including animal feeds, food additives, and medicines.

1. A method for producing methionine, comprising:
1) preparing a reaction solution that includes a methionine precursor which is an O-acetyl homoserine or an O-succinyl homoserine, an enzyme which has the activity of converting the methionine precursor into methionine, and a mixture of methyl mercaptan and dimethyl sulfide; and
2) performing an enzymatic conversion reaction while stirring the reaction solution.

2. The method for producing methionine according to claim 1, wherein the methyl mercaptan is a methyl mercaptan gas or a sodium methyl mercaptan solution.
3. The method for producing methionine according to claim 1, wherein a mixing ratio of methyl mercaptan and dimethyl sulfide is a ratio of methyl mercaptan : dimethyl sulfide of 1:0.05 to 1:1.
4. The method for producing methionine according to claim 3, wherein a mixing ratio of methyl mercaptan and dimethyl sulfide is a ratio of methyl mercaptan : dimethyl sulfide of 1:0.20 to 1:1.
5. The method for producing methionine according to claim 4, wherein a mixing ratio of methyl mercaptan and dimethyl sulfide is a ratio of methyl mercaptan : dimethyl sulfide of 1:0.25 to 1:0.5.

6. The method for producing methionine according to claim 1, wherein the
enzyme which has an activity of converting the methionine precursor into methionine is
the one enzyme or more selected from the group consisting of cystathionine gamma
synthase, O-succinyl homoserine sulfhydrylase and O-acetyl homoserine sulfhydrylase.
7. The method for producing methionine according to claim 1, further comprising terminating the enzymatic conversion reaction.
8. The method for producing methionine according to claim 1, further comprising the purification step of methionine which is produced by enzymatic conversion and contained in a reaction solution.
9. The method for producing methionine according to claim 8, wherein
methionine purification step comprises:
1) separating the microorganism from the enzymatic conversion reaction solution;
2) decoloring and filtering the reaction solution, of which the microorganism is removed; and
3) crystallizing from the filtrate.
10. Methionine prepared by the method as in one of claims 1-9.
11. The methionine according to claim 10, wherein the methionine is in a
form of powder or solution.

Documents

Application Documents

# Name Date
1 6147-CHENP-2011 FORM-18 02-09-2011.pdf 2011-09-02
1 6147-CHENP-2011-RELEVANT DOCUMENTS [09-09-2023(online)].pdf 2023-09-09
2 6147-CHENP-2011-RELEVANT DOCUMENTS [05-09-2022(online)].pdf 2022-09-05
2 6147-CHENP-2011 CORRESPONDENCE OTHERS 02-09-2011.pdf 2011-09-02
3 Form-5.pdf 2011-09-14
3 6147-CHENP-2011-RELEVANT DOCUMENTS [27-09-2021(online)].pdf 2021-09-27
4 Form-3.pdf 2011-09-14
4 6147-CHENP-2011-RELEVANT DOCUMENTS [05-09-2021(online)].pdf 2021-09-05
5 Form-1.pdf 2011-09-14
5 6147-CHENP-2011-RELEVANT DOCUMENTS [09-03-2020(online)].pdf 2020-03-09
6 Drawings.pdf 2011-09-14
6 6147-CHENP-2011-RELEVANT DOCUMENTS [28-03-2019(online)].pdf 2019-03-28
7 6147-CHENP-2011-RELEVANT DOCUMENTS [27-03-2018(online)].pdf 2018-03-27
7 6147-CHENP-2011 POWER OF ATTORNEY 30-11-2011.pdf 2011-11-30
8 6147-CHENP-2011-FORM 3 [31-01-2018(online)].pdf 2018-01-31
8 6147-CHENP-2011 CORRESPONDENCE OTHERS 30-11-2011.pdf 2011-11-30
9 6147-CHENP-2011-PatentCertificate11-07-2017.pdf 2017-07-11
9 6147-CHENP-2011 FORM-1 30-11-2011.pdf 2011-11-30
10 6147-CHENP-2011 CORRESPONDENCE OTHERS 24-01-2012.pdf 2012-01-24
10 6147-CHENP-2011-PatentCertificateCoverLetter.pdf 2017-07-11
11 6147-CHENP-2011 FORM-3 24-01-2012.pdf 2012-01-24
11 Claims_Granted 285058_11-07-2017.pdf 2017-07-11
12 6147-CHENP-2011 ENGLISH TRANSLATION 24-01-2012.pdf 2012-01-24
12 Description_Granted 285058_11-07-2017.pdf 2017-07-11
13 6147-CHENP-2011 FORM-13 13-05-2015.pdf 2015-05-13
13 Drawings_Granted 285058_11-07-2017.pdf 2017-07-11
14 Form 13.pdf 2015-05-18
14 Marked Copy_Granted 285058_11-07-2017.pdf 2017-07-11
15 Form 1.pdf 2015-05-18
15 Written submissions and relevant documents [10-07-2017(online)].pdf 2017-07-10
16 6147-CHENP-2011 CORRESPONDENCE OTHERS 23-07-2015.pdf 2015-07-23
16 Correspondence by Agent_Power of Attorney_29-03-2017.pdf 2017-03-29
17 6147-CHENP-2011-FER.pdf 2016-11-08
17 Claims [21-03-2017(online)].pdf 2017-03-21
18 Description(Complete) [21-03-2017(online)].pdf 2017-03-21
18 Other Document [06-03-2017(online)].pdf 2017-03-06
19 Form 3 [06-03-2017(online)].pdf 2017-03-06
19 Description(Complete) [21-03-2017(online)].pdf_152.pdf 2017-03-21
20 Examination Report Reply Recieved [06-03-2017(online)].pdf 2017-03-06
20 Examination Report Reply Recieved [21-03-2017(online)].pdf 2017-03-21
21 Description(Complete) [06-03-2017(online)].pdf_35.pdf 2017-03-06
21 Form 26 [21-03-2017(online)].pdf 2017-03-21
22 Description(Complete) [06-03-2017(online)].pdf 2017-03-06
22 Other Document [21-03-2017(online)].pdf 2017-03-21
23 Petition Under Rule 137 [21-03-2017(online)].pdf 2017-03-21
24 Description(Complete) [06-03-2017(online)].pdf 2017-03-06
24 Other Document [21-03-2017(online)].pdf 2017-03-21
25 Form 26 [21-03-2017(online)].pdf 2017-03-21
25 Description(Complete) [06-03-2017(online)].pdf_35.pdf 2017-03-06
26 Examination Report Reply Recieved [21-03-2017(online)].pdf 2017-03-21
26 Examination Report Reply Recieved [06-03-2017(online)].pdf 2017-03-06
27 Description(Complete) [21-03-2017(online)].pdf_152.pdf 2017-03-21
27 Form 3 [06-03-2017(online)].pdf 2017-03-06
28 Description(Complete) [21-03-2017(online)].pdf 2017-03-21
28 Other Document [06-03-2017(online)].pdf 2017-03-06
29 6147-CHENP-2011-FER.pdf 2016-11-08
29 Claims [21-03-2017(online)].pdf 2017-03-21
30 6147-CHENP-2011 CORRESPONDENCE OTHERS 23-07-2015.pdf 2015-07-23
30 Correspondence by Agent_Power of Attorney_29-03-2017.pdf 2017-03-29
31 Form 1.pdf 2015-05-18
31 Written submissions and relevant documents [10-07-2017(online)].pdf 2017-07-10
32 Form 13.pdf 2015-05-18
32 Marked Copy_Granted 285058_11-07-2017.pdf 2017-07-11
33 6147-CHENP-2011 FORM-13 13-05-2015.pdf 2015-05-13
33 Drawings_Granted 285058_11-07-2017.pdf 2017-07-11
34 6147-CHENP-2011 ENGLISH TRANSLATION 24-01-2012.pdf 2012-01-24
34 Description_Granted 285058_11-07-2017.pdf 2017-07-11
35 6147-CHENP-2011 FORM-3 24-01-2012.pdf 2012-01-24
35 Claims_Granted 285058_11-07-2017.pdf 2017-07-11
36 6147-CHENP-2011 CORRESPONDENCE OTHERS 24-01-2012.pdf 2012-01-24
36 6147-CHENP-2011-PatentCertificateCoverLetter.pdf 2017-07-11
37 6147-CHENP-2011-PatentCertificate11-07-2017.pdf 2017-07-11
37 6147-CHENP-2011 FORM-1 30-11-2011.pdf 2011-11-30
38 6147-CHENP-2011-FORM 3 [31-01-2018(online)].pdf 2018-01-31
38 6147-CHENP-2011 CORRESPONDENCE OTHERS 30-11-2011.pdf 2011-11-30
39 6147-CHENP-2011-RELEVANT DOCUMENTS [27-03-2018(online)].pdf 2018-03-27
39 6147-CHENP-2011 POWER OF ATTORNEY 30-11-2011.pdf 2011-11-30
40 Drawings.pdf 2011-09-14
40 6147-CHENP-2011-RELEVANT DOCUMENTS [28-03-2019(online)].pdf 2019-03-28
41 Form-1.pdf 2011-09-14
41 6147-CHENP-2011-RELEVANT DOCUMENTS [09-03-2020(online)].pdf 2020-03-09
42 Form-3.pdf 2011-09-14
42 6147-CHENP-2011-RELEVANT DOCUMENTS [05-09-2021(online)].pdf 2021-09-05
43 6147-CHENP-2011-RELEVANT DOCUMENTS [27-09-2021(online)].pdf 2021-09-27
43 Form-5.pdf 2011-09-14
44 6147-CHENP-2011 CORRESPONDENCE OTHERS 02-09-2011.pdf 2011-09-02
44 6147-CHENP-2011-RELEVANT DOCUMENTS [05-09-2022(online)].pdf 2022-09-05
45 6147-CHENP-2011 FORM-18 02-09-2011.pdf 2011-09-02
45 6147-CHENP-2011-RELEVANT DOCUMENTS [09-09-2023(online)].pdf 2023-09-09

Search Strategy

1 6147fer_25-10-2016.pdf

ERegister / Renewals

3rd: 22 Sep 2017

From 26/02/2012 - To 26/02/2013

4th: 22 Sep 2017

From 26/02/2013 - To 26/02/2014

5th: 22 Sep 2017

From 26/02/2014 - To 26/02/2015

6th: 22 Sep 2017

From 26/02/2015 - To 26/02/2016

7th: 22 Sep 2017

From 26/02/2016 - To 26/02/2017

8th: 22 Sep 2017

From 26/02/2017 - To 26/02/2018

9th: 05 Jan 2018

From 26/02/2018 - To 26/02/2019

10th: 27 Nov 2018

From 26/02/2019 - To 26/02/2020

11th: 25 Nov 2019

From 26/02/2020 - To 26/02/2021

12th: 12 Dec 2020

From 26/02/2021 - To 26/02/2022

13th: 27 Nov 2021

From 26/02/2022 - To 26/02/2023

14th: 28 Nov 2022

From 26/02/2023 - To 26/02/2024

15th: 27 Nov 2023

From 26/02/2024 - To 26/02/2025

16th: 12 Dec 2024

From 26/02/2025 - To 26/02/2026